Morphine Sulfate 8 Mg Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 25mg/ml, 4mg/ml, 50mg/ml
Reference Brands: Infumorph(USA), Mitigo,
Category:
Analgesic
Morphine is a pain relieving medicine. It effectively alleviates moderate to severe pain.
Morphine Sulfate 8 mg Injection is available in Injection
and strengths such as 25mg/ml, 4mg/ml, 50mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Morphine Sulfate 8 mg Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Morphine Sulfate 8 mg Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Morphine is a well-known opioid analgesic widely used for the management of moderate to severe pain. It acts on the central nervous system by binding to opioid receptors, primarily the mu-opioid receptors, which helps reduce the perception of pain and produces analgesic effects. Morphine has long been considered the standard reference opioid against which other opioid pain medications are compared due to its well-established effectiveness in pain control.
Traditionally, morphine was mainly used as a short-acting opioid for the treatment of acute pain, such as postoperative pain, trauma-related pain, and severe cancer pain. However, the development of extended-release and controlled-release formulations has expanded its use in the management of chronic pain conditions that require continuous and long-term pain control. These formulations provide sustained analgesic effects over an extended period, helping maintain stable pain relief and reducing the need for frequent dosing.
Morphine undergoes metabolism primarily in the liver, where it is converted into active metabolites that contribute to its analgesic activity. Today, morphine is available in various dosage forms, including immediate-release tablets, extended-release tablets, oral solutions, and injectable formulations, making it an important medication in both acute and chronic pain management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing